James Loerop
EVP Business Development, Anika Therapeutics, Inc.
Companies
- Aclaris Therapeutics, Inc.Chief Business Officer Feb 1, 2022 to now1
- Anika Therapeutics, Inc.EVP Business Development Jul 9, 2019 to Jul 12, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aclaris Therapeutics, Inc. ACRS192,260 shares3$649.8K at $3.38Feb 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 3, 2026Shares withheld for tax 5,937 shares at $3.47 of Aclaris Therapeutics, Inc.3
- Feb 3, 2026Exercised options 20,875 shares of Aclaris Therapeutics, Inc.3
- Feb 1, 2026Shares withheld for tax 10,686 shares at $3.51 of Aclaris Therapeutics, Inc.4
- Feb 1, 2026Exercised options 14,750 shares of Aclaris Therapeutics, Inc.4
- Feb 1, 2026Exercised options 7,500 shares of Aclaris Therapeutics, Inc.4
- Feb 1, 2026Exercised options 11,250 shares of Aclaris Therapeutics, Inc.4
- Jan 2, 2026Shares withheld for tax 6,171 shares at $2.88 of Aclaris Therapeutics, Inc.5
- Jan 2, 2026Exercised options 18,150 shares of Aclaris Therapeutics, Inc.5
- Dec 31, 2025Shares withheld for tax 33,994 shares at $3.01 of Aclaris Therapeutics, Inc.5
- Dec 31, 2025Exercised options 73,750 shares of Aclaris Therapeutics, Inc.5
- Feb 1, 2025Shares withheld for tax 15,447 shares at $2.48 of Aclaris Therapeutics, Inc.6
- Feb 1, 2025Exercised options 14,750 shares of Aclaris Therapeutics, Inc.6
- Feb 1, 2025Exercised options 7,500 shares of Aclaris Therapeutics, Inc.6
- Feb 1, 2025Exercised options 11,250 shares of Aclaris Therapeutics, Inc.6
- Feb 1, 2025Shares withheld for tax 15,980 shares at $2.48 of Aclaris Therapeutics, Inc.7
- Feb 1, 2025Shares withheld for tax 15,980 shares at $2.48 of Aclaris Therapeutics, Inc.8
- Jan 2, 2025Shares withheld for tax 8,575 shares at $2.48 of Aclaris Therapeutics, Inc.9
- Jan 2, 2025Exercised options 18,150 shares of Aclaris Therapeutics, Inc.9
- Dec 31, 2024Shares withheld for tax 32,089 shares at $2.48 of Aclaris Therapeutics, Inc.9
- Dec 31, 2024Exercised options 73,750 shares of Aclaris Therapeutics, Inc.9
- Feb 1, 2024Shares withheld for tax 2,568 shares at $1.20 of Aclaris Therapeutics, Inc.10
- Feb 1, 2024Exercised options 7,500 shares of Aclaris Therapeutics, Inc.10
- Feb 1, 2024Shares withheld for tax 3,853 shares at $1.20 of Aclaris Therapeutics, Inc.10
- Feb 1, 2024Exercised options 11,250 shares of Aclaris Therapeutics, Inc.10
- Aug 28, 2023Bought 14,705 shares at $6.80 of Aclaris Therapeutics, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 5, 2026
- 5SEC EDGARForm 4 filed Jan 5, 2026
- 6SEC EDGARForm 4 filed Feb 4, 2025
- 7SEC EDGARForm 4 filed Feb 3, 2026
- 8SEC EDGARForm 4 filed Feb 3, 2026
- 9SEC EDGARForm 4 filed Jan 3, 2025
- 10SEC EDGARForm 4 filed Feb 5, 2024
- 11SEC EDGARForm 4 filed Aug 28, 2023